FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncoendocrinology and oncogynecology and is intended for estimation of endometrial cancer sensitivity to neoadjuvant therapy with aromatase inhibitors. Before and after the course of neoadjuvant therapy with aromatase inhibitors ultrasonic endometrium thickness by value of M-echo signal and marker Ki-67 expression; and laboratory indices - concentration of estradiole in blood and aromatase activity in tumor tissue are examined. Detected dynamic changes are given definite points. If sum of points is 4 and higher such patients and detected in them neoplasms are referred to group of sensitive to neoadjuvant therapy with aromatase inhibitors.
EFFECT: method allows to estimate potential efficiency of aromatase inhibitors in adjuvant regimen in endometrial cancer therapy.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING TUMOR HORMONE DEPENDENCE OF LOW-DIFFERENTIATED ENDOMETRIUM CARCINOMA AND ITS SENSITIVITY TO AROMATASE INHIBITORS | 2006 |
|
RU2317555C2 |
| METHOD OF EVALUATING ESTROGEN DEPENDENCE OF HIGH-DIFFERENTIATED THYROID CANCER | 2010 |
|
RU2422834C1 |
| METHOD FOR PREDICTION OF RECURRENT ENDOMETRIOID OVARIAN CYSTS | 2018 |
|
RU2694882C1 |
| BREAST CANCER OUTCOME PREDICTION METHOD | 2008 |
|
RU2361222C1 |
| METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER | 2005 |
|
RU2297798C1 |
| METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
| METHOD FOR CORRECTION OF HYPERESTRADIOLEMIA AND NORMOGONADOTROPIC HYPOGONADISM IN MALES | 2010 |
|
RU2474424C2 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
| METHOD OF ASSESSING OF AROMATASE ACTIVITY OF OVARIAN FOLLICLES | 2015 |
|
RU2602456C1 |
| METHOD FOR AROMATASE ACTIVITY TEST | 2012 |
|
RU2481587C1 |
